教育背景：北京大学医学部博士毕业，2013.5-2014.5于英国卡迪夫大学博士后研究；
学术方向：进展期胃癌围术期药物治疗联合根治手术的综合治疗；
科研成果:承担国家青年自然科学基金一项，北京市医院管理局青年人才培养“青苗”计划；第一作者发表SCI文章10篇，累计IF 103分；
临床工作：进展期胃癌的围手术期药物治疗（化疗，靶向，免疫治疗）以及腹腔镜微创手术、全腹腔镜下消化道重建，尤其是胃食管结合部癌的术前药物治疗联合微创手术，胃的功能保留以及高位吻合。合并肝转移、腹主动脉旁淋巴结转移的晚期胃癌药物转化治疗以及手术。结直肠癌以及低位直肠癌的微创手术，晚期结肠癌的多学科协作以及转化治疗后手术治疗；胃肠道间质瘤，神经内分泌癌的药物治疗联合手术等。
发表论文
第一作者发表文章
Gao X, Ji K, Jia Y, et al. Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial. Nat Med. 2024. 30(7): 1943-1951 IF：58.7
Wang Y, Gan X, Cheng X, et al. ABCC2 induces metabolic vulnerability and cellular ferroptosis via enhanced glutathione efflux in gastric cancer. Clin Transl Med. 2024. 14(8): e1754. IF：7.9
Li, Ziyu#; Jia, Yongning#; Zhu, Honglin #; Yuan, Hongling; Xing, Xiaofang; Xin, Yaqun; Ma, Tonghui; Pang, Fei; Zhang, Yan; Hu, Ying; Jia, Shuqin*; Ji, Jiafu*，Genomic landscape of microsatellite instability in Chinese tumors: a comparison of Chinese and TCGA cohorts， International Journal of Cancer，2022，IF：5.507
Xing X#;Shi J#;Jia Y#;Dou Y;Li Z;Dong B;Guo T;Cheng X;Li X;Du H;Hu Y;Jia S*;Zhang J*;Li Z*;Ji J*; Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis. Journal for immunotherapy of cancer，2022， IF：10.9
Li Z#;Jia Y#;Zhu H#;Xing X#;Pang F;Shan F;Li S;Wang D;Zhao F;Ma T;Wang S; Ji J*; Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy. Gastric Cancer ，2021，IF：6.253
Jia Y#;Li Z#;Cheng X;Wu X;Pang F;Shi J;Li S;Li X;Hu Y;Zhang L;Ji J*，Depletion of death-associated protein-3 induces chemoresistance in gastric cancer cells through the β-catenin/LGR5/Bcl-2 axis. Journal of investigative medicine，2019, IF：2.3
Jia Y, Ye L, Ji K, et al. Death-associated protein-3, DAP-3, correlates with preoperative chemotherapy effectiveness and prognosis of gastric cancer patients following perioperative chemotherapy and radical gastrectomy. Br J Cancer. 2014. 110(2): 421-9 IF：4.84
参与发表文章：
Yin S;Xi R;Wu A;Wang S;Li Y;Wang C;Tang L;Xia Y;Yang D;Li J;Ye B;Yu Y;Wang J;Zhang H;Ren F;Zhang Y;Shen D;Wang L;Ying X;Li Z;Bu Z;Ji X;Gao X;Jia Y;Jia Z;Li N;Li Z;Ji JF;Xi JJ; Patient-derived tumor-like cell clusters for drug testing in cancer therapy. Science translational medicine，2020，IF：17.96
